When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FBRX - Forte Biosciences: Microbiome Therapeutics For Skin Disease
Forte Biosciences Inc.
Forte Biosciences is developing a first-in-class drug for eczema, which affects over 16M patients in the US.
Phase 1 data for Forte's lead asset, FB-401, has shown exceptional safety and supported a phase 2 trial that is expected to report data in mid-2021.
This has created a compelling entry point in an upcoming binary event that, in our opinion, has a favorable risk-reward profile for an opportunistic investment.